Literature DB >> 33270608

Sex Differences in HIV Testing - 20 PEPFAR-Supported Sub-Saharan African Countries, 2019.

Bakary Drammeh, Amy Medley, Helen Dale, Anindya K De, Shane Diekman, Randy Yee, Tiffiany Aholou, Arielle Lasry, Andrew Auld, Brittney Baack, Wayne Duffus, Ebrahim Shahul, Vincent Wong, Michael Grillo, Teeb Al-Samarrai, Shabeen Ally, Mtemwa Nyangulu, Rose Nyirenda, Jacobus Olivier, Thato Chidarikire, Nompumelelo Khanyile, Alick A Kayange, Oscar Ernest Rwabiyago, Upendo Kategile, Jema Bisimba, Rachel A Weber, Gertrude Ncube, Onesimo Maguwu, Ismelda Pietersen, Denis Mali, Edington Dzinotyiweyi, Lisa Nelson, Matovu John Bosco, Kwarisiima Dalsone, Madina Apolot, Samson Anangwe, Leonard K Soo, Mary Mugambi, Andre Mbayiha, Placidie Mugwaneza, Samuel S Malamba, Arlene Phiri, Tina Chisenga, Mary Boyd, Chanie Temesgan, Mesfin Shimelis, Teklu Weldegebreal, Mirtie Getachew, Shirish Balachandra, Ehui Eboi, Willibord Shasha, Nicole Doumatey, Didier Adjoua, Chidozie Meribe, Jerry Gwamna, Pamela Gado, Ima John-Dada, Elie Mukinda, Luc F Kamanga Lukusa, Lucien Kalenga, Sudhir Bunga, Victoria Achyut, John Mondi, Peter Loeto, Goabaone Mogomotsi, Jenny Ledikwe, Puleng Ramphalla, Mphotleng Tlhomola, Justine K Mirembe, Tse Nkwoh, Laura Eno, Leonard Bonono, Nely Honwana, Noela Chicuecue, Ana Simbine, Inacio Malimane, Lenhle Dube, Munamato Mirira, Phumzile Mndzebele, Alean Frawley, Yolanda Marina Rebello Cardo, Stephanie Behel.   

Abstract

Despite progress toward controlling the human immunodeficiency virus (HIV) epidemic, testing gaps remain, particularly among men and young persons in sub-Saharan Africa (1). This observational study used routinely collected programmatic data from 20 African countries reported to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) from October 2018 to September 2019 to assess HIV testing coverage and case finding among adults (defined as persons aged ≥15 years). Indicators included number of HIV tests conducted, number of HIV-positive test results, and percentage positivity rate. Overall, the majority of countries reported higher HIV case finding among women than among men. However, a slightly higher percentage positivity was recorded among men (4.7%) than among women (4.1%). Provider-initiated counseling and testing (PITC) in health facilities identified approximately two thirds of all new cases, but index testing had the highest percentage positivity in all countries among both sexes. Yields from voluntary counseling and testing (VCT) and mobile testing varied by sex and by country. These findings highlight the need to identify and implement the most efficient strategies for HIV case finding in these countries to close coverage gaps. Strategies might need to be tailored for men who remain underrepresented in the majority of HIV testing programs.

Entities:  

Year:  2020        PMID: 33270608      PMCID: PMC7714024          DOI: 10.15585/mmwr.mm6948a1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


Despite progress toward controlling the human immunodeficiency virus (HIV) epidemic, testing gaps remain, particularly among men and young persons in sub-Saharan Africa (). This observational study used routinely collected programmatic data from 20 African countries reported to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) from October 2018 to September 2019 to assess HIV testing coverage and case finding among adults (defined as persons aged ≥15 years). Indicators included number of HIV tests conducted, number of HIV-positive test results, and percentage positivity rate. Overall, the majority of countries reported higher HIV case finding among women than among men. However, a slightly higher percentage positivity was recorded among men (4.7%) than among women (4.1%). Provider-initiated counseling and testing (PITC) in health facilities identified approximately two thirds of all new cases, but index testing had the highest percentage positivity in all countries among both sexes. Yields from voluntary counseling and testing (VCT) and mobile testing varied by sex and by country. These findings highlight the need to identify and implement the most efficient strategies for HIV case finding in these countries to close coverage gaps. Strategies might need to be tailored for men who remain underrepresented in the majority of HIV testing programs. In 2014, the Joint United Nations Programme on AIDS (UNAIDS) launched its 90–90–90 strategy for ending the global HIV pandemic: 90% of all persons living with HIV/AIDS (PLHIV) know their status; of these, 90% are receiving antiretroviral treatment (ART); and of these, 90% are virally suppressed (). PEPFAR provides guidance on reaching these targets to all its supported countries (). PEPFAR also collects data on standardized indicators as part of its Monitoring, Evaluation, and Reporting system (). These data are collected by facility and community sites and are reported quarterly by each country program. Routine program data reported to PEPFAR from October 2018 to September 2019 from 20 sub-Saharan African countries and modeling data from UNAIDS were used to identify progress toward achieving the first of the three 90–90–90 goals. These countries were selected because they collectively represent the highest HIV prevalence among PEPFAR-supported countries. Indicators used included the number of HIV tests conducted among adults, the number of HIV-positive test results, and yield (or percentage positivity) defined as the number of positive test results divided by the total number of tests reported. Results for each country are presented overall and disaggregated by sex and testing strategy. Testing strategies include index testing (offering an HIV test to the partners and biologic children of PLHIV), PITC (providers recommending an HIV test as part of routine care), VCT (HIV testing at a clinic dedicated to this purpose), and mobile testing (HIV testing offered at an ad hoc location in the community [e.g., van, workplace, or school]).The standard test statistic for the difference in proportions between men and women was computed on the basis of pooled variance formulation. P-values <0.05 were considered statistically significant for each pairwise difference and were computed under the asymptomatic normality assumption (). PITC was used as the reference strategy for comparisons among strategies because the highest number of new HIV cases are identified by PITC in sub-Saharan Africa (). The percentage positivity for the three other strategies (index testing, VCT, and mobile testing) was compared with PITC for each country and by sex. From October 2018 to September 2019, PEPFAR supported 60,945,355 tests that identified 2,603,560 adults with positive HIV test results (5.0% yield; Table 1). Approximately one fifth (19.9%) of all testing occurred in South Africa. More women received tests than men (women, 40,263,510; men, 20,681,845). However, yield was slightly higher among men (970,100; 4.7% yield) than among women (1,633,460; 4.1% yield). Over one half (51.6%) of all HIV-positive results among men were reported by South Africa, Tanzania, and Zambia, and approximately one third (29.2%) were reported by South Africa alone.
TABLE 1

Adult human immunodeficiency virus (HIV) prevalence, by sex — 20 PEPFAR-supported African countries, October 2018–September 2019*

CountryAllHIV tests conducted
AllHIV tests positive
No.
No. (%)
MenWomenMenWomen
Rwanda
888,336
371,405
516,931
7,343 (0.8)
2,929 (0.8)
4,414 (0.9)
Eswatini
305,714
106,448
199,266
21,341 (7.0)
8,697 (8.2)
12,644 (6.3)
Botswana
278,908
119,530
159,378
14,407 (5.2)
6,105 (5.1)
8,302 (5.2)
Namibia
398,722
130,566
268,156
14,078 (3.5)
5,385 (4.1)
8,693 (3.2)
Malawi
3,741,494
1,362,235
2,379,259
122,509 (3.3)
52,870 (3.9)
69,639 (2.9)
South Africa
12,131,042
3,996,848
8,134,194
759,465 (6.3)
267,255 (6.7)
492,210 (6.1)
Zimbabwe
2,059,970
709,379
1,350,591
112,605 (5.5)
43,340 (6.1)
69,265 (5.1)
Kenya
9,325,119
3,248,359
6,076,760
168,809 (1.8)
60,515 (1.9)
108,294 (1.8)
Zambia
4,666,548
1,843,640
2,822,908
275,966 (5.9)
111,599 (6.1)
164,367 (5.8)
Lesotho
739,505
247,653
491,852
28,899 (3.9)
11,453 (4.6)
17,446 (3.5)
Uganda
4,872,644
1,858,346
3,014,298
161,742 (3.3)
60,855 (3.3)
100,887 (3.3)
Ethiopia
401,572
153,500
248,072
8,729 (2.2)
3,543 (2.3)
5,186 (2.1)
Tanzania
6,930,758
2,415,017
4,515,741
314,364 (4.5)
121,603 (5.0)
192,761 (4.3)
Cameroon
839,762
317,881
521,881
32,435 (3.9)
11,648 (3.7)
20,787 (4.0)
Mozambique
5,651,254
1,519,954
4,131,300
281,022 (5.0)
103,433 (6.8)
177,589 (4.3)
Nigeria
4,309,213
1,348,056
2,961,157
158,351(3.7)
55,834 (4.1)
102,517 (3.5)
Côte d’Ivoire
2,200,382
564,945
1,635,437
60,058 (2.7)
19,713 (3.5)
40,345 (2.5)
DRC
811,233
235,984
575,249
41,898 (5.2)
16,062 (6.8)
25,836 (4.5)
Angola
141,292
49,215
92,077
9,208 (6.5)
3,253 (6.6)
5,955 (6.5)
South Sudan
251,887
82,884
169,003
10,331 (4.1)
4,008 (4.8)
6,323 (3.7)
Total 60,945,355 20,681,845 40,263,510 2,603,560 (5.0) 970,100 (4.7) 1,633,460 (4.1)

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019.

Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief.

* Nine of the 20 countries account for 90% of HIV prevalence: Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. Six countries have achieved the first 90 target (Botswana, Eswatini, Kenya, Lesotho, Namibia, and South Africa), and knowledge of HIV status is <70% in Angola (69%), DRC (49%), and South Sudan (24%).

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019. Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief. * Nine of the 20 countries account for 90% of HIV prevalence: Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. Six countries have achieved the first 90 target (Botswana, Eswatini, Kenya, Lesotho, Namibia, and South Africa), and knowledge of HIV status is <70% in Angola (69%), DRC (49%), and South Sudan (24%). Across the 19 countries (excluding Malawi because of limited data), PITC identified the most PLHIV (63.2%) compared with index testing (17.4%), VCT (11.0%), and mobile testing (8.4%). HIV case finding among men followed a similar pattern: PITC identified 57.7% of HIV-positive men, followed by index testing (21.4%), VCT (11.9%), and mobile testing (9.0%). Six countries accounted for 80.2% of HIV-positive men identified through PITC: South Africa (220,940), Mozambique (56,960), Tanzania (52,574), Zambia (38,991), Kenya, (28,814), and Uganda (26,421). Additional data for new HIV cases identified across the four HIV testing strategies both overall and by sex are provided (Table 2).
TABLE 2

Number and percentage of human immunodeficiency virus (HIV)–positive adults Identified, by four HIV-testing strategies, overall and by sex — 20 PEPFAR-supported countries, October 2018–September 2019*

CountryIndex testing
Provider-initiated testing
Voluntary counseling and testing
Mobile testing
All
Men
Women
All
Men
Women
All
Men
Women
All
Men
Women
No./Total no.(%)§% Positive% PositiveNo./Total no. (%)% Positive% PositiveNo./Total no. (%)% Positive% PositiveNo./total no. (%)% Positive% Positive
Rwanda
1.4/26.6 (5.1)
4.6
5.8
2.4/545.9 (0.5)
0.5
0.4
2.6/259.9 (1.0)
0.8
1.2
0.9/55.9 (1.7)
1.0
2.8
Eswatini
3.5/13.9 (25.5)
25.6
25.4
11.7/214.9 (5.5)
6.6
5.0
4.0/46.6 (8.5)
7.9
9.1
2.1/30.3 (6.9)
6.5
7.2
Botswana
2.3/16.9 (13.8)
14.6
12.9
9.8/187.5 (5.3)
5.2
5.3
0.5/17.3 (3.0)
2.6
3.3
1.7/57.1 (3.0)
2.6
3.4
Namibia**
2.6/16.8 (15.6)
15.7
15.5
10.1/347.8 (2.9)
3.3
2.7
1.3/32.6 (3.9)
3.8
4.0
0.07/1.5 (4.5)
4.4
4.6
Malawi††
8.9/29.8 (30.1)
30.5
29.6
29.7/1,025.5 (2.9)
3.4
2.7
17.5/317.5 (5.5)
4.9
6.1
5.6/63.5 (8.9)
7.5
11.1
South Africa
28.5/92.4 (30.9)
30
31.7
647.8/10.2 (6.3)
6.9
6.0
2.2/26.3 (8.3)
7.3
11.2
80.9/1,747.6 (4.6)
4.2
4.9
Zimbabwe
23.8/73.8 (32.2)
34.5
30.2
79.6/1,904.1 (4.2)
4.4
4.1
5.0/45.5 (11.1)
9.7
11.9
4.2/36.6 (11.5)
9.4
13.5
Kenya
51.7/294.4 (17.6)
14.5
21.0
91.7/7,379.6 (1.2)
1.2
1.2
23.7/1,361.9 (1.7)
1.4
2.0
1.8/289.1 (0.6)
0.4
0.7
Zambia
63.6/222.2 (28.6)
26.4
30.7
105.1/2,884.3 (3.6)
3.8
3.6
87.3/1,455.2 (6.0)
5.6
6.3
19.9/104.8 (19.0)
15.7
22.0
Lesotho
4.2/17.3 (24.3)
25.4
23.3
20.2/597.0 (3.4)
4.3
3.0
0.4/7.8 (4.8)
3.3
5.7
4.1/117.4 (3.5)
2.7
4.5
Uganda
34.6/189.8 (18.2)
16.1
20.4
80.3/3,231.7 (2.5)
2.4
2.5
33.9/1,070.8 (3.2)
2.9
3.4
12.9/380.4 (3.4)
3.1
3.7
Ethiopia
2.8/26.1 (10.8)
10.5
11.1
4.3/313.6 (1.4)
1.5
1.3
0.9/40.8 (2.3)
1.8
2.4
0.7/21.0 (3.2)
2.5
3.9
Tanzania
116.5/544.0 (21.4)
19.9
22.9
153.9/5,192.5 (3.0)
3.2
2.9
5.0/103.5 (4.9)
3.8
5.8
38.9/1,090.6 (3.6)
3.4
3.7
Cameroon
5.3/46.3 (11.5)
9.5
14.3
21.4/708.1 (3.0)
2.8
3.1
4.5/66.2 (6.9)
5.1
8.3
1.1/19.1 (5.8)
4.5
7
Mozambique
40.7/151.3 (26.9)
24.9
28.9
177.4/4,540.9 (3.9)
5.7
3.4
54.3/863.6 (6.3)
6.1
6.4
8.6/95.5 (9.0)
7.2
11.6
Nigeria
25.1/103.5 (24.3)
19.5
30.6
79.4/3,007.8 (2.6)
3.2
2.4
38.1/947.0 (4.0)
3.3
4.6
15.8/250.9 (6.3)
6.1
6.4
Côte d’Ivoire
14.1/88.2 (16.0)
12.4
20.7
39.5/1,983.5 (2.0)
2.4
1.9
0.3/5.2 (6.6)
5.9
7.4
6.1/123.4 (4.9)
4.2
5.5
DRC
9.3/29.7 (31.4)
30.4
32.6
23.8/656.3 (3.6)
5.1
3.2
1.7/37.1 (4.6)
3.1
7.1
7.0/88.1 (8.0)
6.3
9.4
Angola
0.7/2.0 (37.3)
29.8
44.3
3.7/83.3 (4.5)
5
4.2
3.5/32.7 (10.8)
8.5
13.2
1.2/23.2 (5.2)
4.5
5.4
South Sudan
0.5/4.9 (11.0)
11.4
10.7
6.1/186.4 (3.3)
4.5
2.8
2.9/48.9 (6.0)
5.1
6.9
0.7/11.7 (6.4)
4.1
8.7
Total 440.5/1,990.0 (22.1) 20.1 24.3 1,598.2/45,255.4 (3.5) 3.9 2.7 289.7/6,786.8 (4.3) 3.8 4.6 214.4/4,607.9 (4.7) 4.2 5.0

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019.

Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief.

* Breakdown by strategy for 19 countries (excluding Malawi because of limited data).

† Number of HIV tests positive divided by the number of HIV tests conducted. Numbers are reported in thousands with one decimal place.

§ % indicates percent yield.

Statistically significant difference between men and women at p-value <0.05. The p-values were calculated based on z-tests for differences in binomial proportions with pooled variance.

** Community index testing program yield of 22.6% overall across adults.

Data are from 5.5 districts (N = 28) in Malawi.

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019. Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief. * Breakdown by strategy for 19 countries (excluding Malawi because of limited data). † Number of HIV tests positive divided by the number of HIV tests conducted. Numbers are reported in thousands with one decimal place. § % indicates percent yield. Statistically significant difference between men and women at p-value <0.05. The p-values were calculated based on z-tests for differences in binomial proportions with pooled variance. ** Community index testing program yield of 22.6% overall across adults. Data are from 5.5 districts (N = 28) in Malawi. Although PITC identified more PLHIV than any other testing strategy, the percentage positivity of index testing was higher than PITC in all countries and for both sexes (Table 3).The number of PLHIV identified through index testing ranged from 500 in South Sudan (11.0% yield) to 116,500 in Tanzania (21.4% yield) (Table 2). The five countries that identified the most PLHIV through index testing were Uganda (34,585), Mozambique (40,681), Kenya (51,717), Zambia (63,587), and Tanzania (116,546), and yields varied from 17.6% (Kenya) to 28.6% (Zambia). These countries also accounted for two thirds (69.7%) of all HIV-positive men identified through index testing: Uganda (15,313), Mozambique (19,064), Kenya (22,259), Zambia (28,383), and Tanzania (52,040). The contribution of index testing to the total number of HIV-positive men identified in these five countries ranged from 18.1% (Mozambique) to 42.8% (Tanzania).
TABLE 3

Percentage positivity of four human immunodeficiency virus (HIV) testing strategies in identifying new HIV-positive adults, stratified by sex — 20 PEPFAR-supported countries, October 2018–September 2019*

Country% Yield
Men
Women
PITC as reference*Index testingVCT§Mobile testingPITC as referenceIndex testingVCTMobile testing
Rwanda
0.5
4.6**
0.8
1
0.4
5.8**
1.2
2.8**
Eswatini
6.6
25.6**
7.9
6.5
5
25.4**
9.1**
7.2**
Botswana
5.2
14.6**
2.6
2.6**
5.3
12.9**
3.3
3.4
Namibia
3.3
15.7**
3.8
4.4
2.7
15.5**
4.0
4.6
Malawi
3.4
30.5**
4.9**
7.6**
2.7
29.6**
6.1**
11.1**
South Africa
6.9
30.0**
7.3
4.2**
6
31.7**
11.2**
4.9**
Zimbabwe
4.4
34.5**
9.7**
9.4**
4.1
30.2**
11.9**
13.5**
Kenya
1.2
14.5**
1.4
0.4
1.2
21.0**
2.0**
0.7
Zambia
3.8
26.4**
5.6**
15.7**
3.6
30.7**
6.3**
22.0**
Lesotho
4.3
25.4**
3.3
2.7**
3
23.3**
5.7
4.5**
Uganda
2.4
16.1**
2.9**
3.1**
2.5
20.4**
3.4**
3.7**
Ethiopia
1.5
10.5**
1.8
2.5
1.3
11.1**
2.4
3.9**
Tanzania
3.2
19.9**
3.8
3.4
2.9
22.9**
5.8**
3.7**
Cameroon
2.8
9.5**
5.1**
4.5
3.1
14.3**
8.3**
7.0**
Mozambique
5.7
24.9**
6.1
7.2**
3.4
28.9**
6.4**
11.6**
Nigeria
3.2
19.5**
3.3
6.1**
2.4
30.6**
4.6**
6.4**
Côte d’Ivoire
2.4
12.4**
5.9**
4.2**
1.9
20.7**
7.4**
5.5**
DRC
5.1
30.4**
3.1
6.3
3.2
32.6**
7.1**
9.4**
Angola
5
29.8**
8.5**
4.5
4.2
44.3**
13.2**
5.4
South Sudan4.511.4**5.14.12.810.7**6.9**8.7**

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019.

Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief; PITC = provider-initiated testing and counseling; VCT = voluntary counseling and testing.

* PITC for HIV testing of persons at health facilities.

† Index testing of persons with new HIV diagnoses.

§ VCT to determine HIV status.

¶ Mobile testing outside health facilities.

** Statistically significant differences between PITC as reference compared with other strategies at p-values <0.05. The p-values were calculated on the basis of z-tests for differences in binomial proportions with pooled variance.

Source: PEPFAR Monitoring, Evaluation, and Reporting data for Accountability, Transparency, and Impact Monitoring database, October 2018–September 2019. Abbreviations: DRC = Democratic Republic of Congo; PEPFAR = U.S. President’s Emergency Plan for AIDS Relief; PITC = provider-initiated testing and counseling; VCT = voluntary counseling and testing. * PITC for HIV testing of persons at health facilities. † Index testing of persons with new HIV diagnoses. § VCT to determine HIV status. ¶ Mobile testing outside health facilities. ** Statistically significant differences between PITC as reference compared with other strategies at p-values <0.05. The p-values were calculated on the basis of z-tests for differences in binomial proportions with pooled variance. The yield for VCT among men was significantly higher than for PITC in eight countries (Angola, Cameroon, Côte d’Ivoire, Malawi, Mozambique, Uganda, Zambia, and Zimbabwe) but was lower in the Democratic Republic of Congo (DRC) (Table 3). Similarly, mobile testing had a significantly higher yield than PITC among men in Cameroon, Côte d’Ivoire, DRC, Malawi, Mozambique, Nigeria, Uganda, and Zimbabwe but a lower yield in Botswana, Lesotho, and South Africa. Among women, VCT had a significantly higher yield than PITC in all countries except Botswana, whereas mobile testing had a significantly higher yield than PITC in all but three countries (Botswana, South Africa, and Kenya). These findings will help guide the Ministries of Health in selecting specific testing strategies to increase HIV-testing coverage. This will help identify persons living with HIV infection.

Discussion

PITC identified the largest number of PLHIV, but index testing was more efficient at finding PLHIV as evidenced by a higher positivity rate. Several factors, including the absolute number of PLHIV identified, testing yield, cost per diagnosis, and the ability to reach persons with undiagnosed HIV infection, can help identify the best HIV-testing approach (). Although an efficient testing strategy in terms of identifying PLHIV, index testing is resource-intensive (). For large yields of persons with a new HIV diagnosis to be identified, index testing requires a massive, potentially expensive, scale-up (). However, Kenya, Tanzania, Mozambique, and Uganda have achieved substantial scale-up, demonstrating the feasibility of index testing in sub-Saharan Africa. Although the majority of PLHIV in sub-Saharan Africa receive their diagnosis through PITC, findings from this analysis show that index testing is identifying new PLHIV in many countries. Screening tools that use a combination of clinical and behavioral questions to identify persons most likely to be HIV-positive can increase the percentage positivity of PITC. However, these screening tools must be validated to ensure high sensitivity and good specificity to avoid missed opportunities for diagnosis (). These findings show that men are less likely to be tested for HIV than women and represented 37% of HIV-positive results. Although women were twice as likely to be tested for HIV, approximately one third of new cases identified occurred among men. In all countries, women are routinely tested for HIV as part of antenatal testing, regardless of their clinical or behavioral risk factors. This might help explain why the number of tests conducted was higher among women compared with men, but the percent positivity rate was lower. PITC and index testing identified the most HIV-positive men, but mobile testing remains an important strategy to reach men who are unable or unwilling to attend health care facilities. Interventions that might improve coverage among men include flexible hours, male counselors, and integration of HIV testing into screening for other chronic conditions (). Although not included in this analysis, HIV self-testing, directly offered within health facilities () or distributed by sex or needle-sharing partners as part of index testing (), might also be an efficient method for reaching men. The findings in this report are subject to at least three limitations. First, cost data are lacking. Second, data quality varies across countries despite PEPFAR’s monitoring and reporting guidance. Finally, PITC data include antenatal testing, which results in more testing among women. Testing antenatal women at lower risk also explains why the yield for PITC is lower for women than men, even though the yield is higher for women with the other three testing strategies. Strengths include the number of countries involved in the analysis and the volume of testing data collected by implementing partners. As more PLHIV are identified, finding the remaining PLHIV will become more difficult and expensive because new cases will be harder to find. Multiple testing strategies, tailored to the epidemiologic context and targeted to populations with low access to HIV testing, can help reach these persons. Recency testing now allows programs to identify persons infected with HIV in the past year as well as clusters of incident cases. Immediate and intensified index testing efforts targeted to these clusters might reduce transmission and help countries achieve epidemic control ().

What is already known on this topic?

Identifying persons with HIV infection and initiating treatment are critical to ending the HIV epidemic by 2030. Despite global progress, testing gaps remain, particularly for men.

What is added by this report?

From October 2018 to September 2019, men in 20 sub-Saharan African countries were half as likely as women to receive an HIV test, and 37% of the HIV-positive results were among men. Similar sex differences were observed across HIV testing strategies based upon percent positivity rates.

What are the implications for public health practice?

These results highlight provider-initiated testing and index testing as strategies that might improve HIV testing coverage and maximize the number of persons newly identified as HIV-positive in 20 African countries.
  6 in total

1.  Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial.

Authors:  Kathryn Dovel; Frackson Shaba; O Agatha Offorjebe; Kelvin Balakasi; Mike Nyirenda; Khumbo Phiri; Sundeep K Gupta; Vincent Wong; Chi-Hong Tseng; Brooke E Nichols; Refiloe Cele; Eric Lungu; Tobias Masina; Thomas J Coates; Risa M Hoffman
Journal:  Lancet Glob Health       Date:  2020-02       Impact factor: 26.763

2.  Tracking with recency assays to control the epidemic: real-time HIV surveillance and public health response.

Authors:  Andrea A Kim; Stephanie Behel; Sanny Northbrook; Bharat S Parekh
Journal:  AIDS       Date:  2019-07-15       Impact factor: 4.177

3.  Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya.

Authors:  Monisha Sharma; Jennifer A Smith; Carey Farquhar; Roger Ying; Peter Cherutich; Matthew Golden; Beatrice Wamuti; David Bukusi; Hans Spiegel; Ruanne V Barnabas
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

4.  Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat.

Authors:  Kevin M De Cock; Joseph L Barker; Rachel Baggaley; Wafaa M El Sadr
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

5.  Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.

Authors:  Monisha Sharma; Ruanne V Barnabas; Connie Celum
Journal:  PLoS Med       Date:  2017-04-11       Impact factor: 11.069

6.  HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial.

Authors:  Augustine T Choko; Elizabeth L Corbett; Nigel Stallard; Hendramoorthy Maheswaran; Aurelia Lepine; Cheryl C Johnson; Doreen Sakala; Thokozani Kalua; Moses Kumwenda; Richard Hayes; Katherine Fielding
Journal:  PLoS Med       Date:  2019-01-02       Impact factor: 11.069

  6 in total
  6 in total

1.  Screening Adults for HIV Testing in the Outpatient Department: An Assessment of Tool Performance in Malawi.

Authors:  Corrina Moucheraud; Risa M Hoffman; Kelvin Balakasi; Vincent Wong; Maria Sanena; Sundeep Gupta; Kathryn Dovel
Journal:  AIDS Behav       Date:  2021-08-11

2.  Characteristics and Sexual Risk Behavior of Men Who Never Tested for HIV in Zambia.

Authors:  Maureen Muchimba; Cosmas Zyambo
Journal:  Am J Mens Health       Date:  2021 Nov-Dec

Review 3.  Interventions to Increase HIV Testing Uptake in Global Settings.

Authors:  Radhika Sundararajan; Matthew Ponticiello; Denis Nansera; Kidola Jeremiah; Winnie Muyindike
Journal:  Curr HIV/AIDS Rep       Date:  2022-04-20       Impact factor: 5.495

4.  Interpreting declines in HIV test positivity: an analysis of routine data from Zimbabwe's national sex work programme, 2009-2019.

Authors:  Harriet S Jones; Bernadette Hensen; Sithembile Musemburi; Lilian Chinyanganya; Albert Takaruza; Sungai T Chabata; Primrose Matambanadzo; Brian Rice; Frances M Cowan; James R Hargreaves
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

5.  Individual- and Facility-Level Factors Associated with Facility Testing among Men in Malawi: Findings from a Representative Community Survey.

Authors:  Kelvin Balakasi; Brooke E Nichols; Misheck Mphande; Christian Stillson; Shaukat Khan; Pericles Kalande; Isabella Robson; Maria Sanena; Khumbo Ng'ona; Joep J van Oosterhout; Naoko Doi; Kathryn Dovel
Journal:  Diagnostics (Basel)       Date:  2021-05-26

6.  Unawareness of HIV Infection Among Men Aged 15-59 Years in 13 Sub-Saharan African Countries: Findings From the Population-Based HIV Impact Assessments, 2015-2019.

Authors:  Christine A West; Gregory C Chang; Dustin W Currie; Rachel Bray; Steve Kinchen; Stephanie Behel; Rachel McCullough-Sanden; Andrea Low; Anne Bissek; Judith D Shang; Clement B Ndongmo; Emily K Dokubo; Shirish Balachandra; Legre R Lobognon; Lenhle Dube; Harriet Nuwagaba-Biribonwoha; Michelle Li; Munyaradzi Pasipamire; Yimam Getaneh; Sileshi Lulseged; Frehywot Eshetu; Leonard Kingwara; Emily Zielinski-Gutierrez; Mphotleng Tlhomola; Puleng Ramphalla; Thokozani Kalua; Andrew F Auld; Daniel B Williams; Eric Remera; Gallican N Rwibasira; Veronicah Mugisha; Samuel S Malamba; Jeremiah Mushi; Mohamed F Jalloh; George S Mgomella; Wilford L Kirungi; Sam Biraro; Anna C Awor; Danielle T Barradas; Owen Mugurungi; John H Rogers; Megan Bronson; Stephane M Bodika; Aderonke Ajiboye; Nicholas Gaffga; Carole Moore; Hetal K Patel; Andrew C Voetsch
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.